Skip to main content

  • Intranet
  • News & Events
  • Careers
  • Give

Duke Human Vaccine Institute

  • About Us
    • History
    • Leadership
    • Faculty
    • Careers
    • Mentoring
    • Diversity and Inclusion
    • News & Events
    • Publications
    • Science Culture and Accountability
  • Programs and Centers
    • Duke Consortia for HIV/AIDS Vaccine Development
    • Collaborative Influenza Vaccine Innovation Centers
    • HIV Vaccine Research and Development
    • Collaboration for AIDS Vaccine Discovery
    • Duke Regional Biocontainment Laboratory
    • Duke Vaccine Trial Unit
    • Mother-Infant Health Programs
    • Immunology Virology Quality Assessment Center
    • Pandemic Preparedness Programs
  • Diseases & Research
    • Priority Pathogens
    • Shared Resources
    • Quantitative Research Division
    • Structural Biology Division
    • Good Manufacturing Practice Facility
Menu
  • About Us
    • History
    • Leadership
    • Faculty
    • Careers
    • Mentoring
    • Diversity and Inclusion
    • News & Events
    • Publications
    • Science Culture and Accountability
  • Programs and Centers
    • Duke Consortia for HIV/AIDS Vaccine Development
    • Collaborative Influenza Vaccine Innovation Centers
    • HIV Vaccine Research and Development
    • Collaboration for AIDS Vaccine Discovery
    • Duke Regional Biocontainment Laboratory
    • Duke Vaccine Trial Unit
    • Mother-Infant Health Programs
    • Immunology Virology Quality Assessment Center
    • Pandemic Preparedness Programs
  • Diseases & Research
    • Priority Pathogens
    • Shared Resources
    • Quantitative Research Division
    • Structural Biology Division
    • Good Manufacturing Practice Facility

Search form

News & Events

  • News
  • Announcements
  • Events
November 01, 2021

WHQR: "Duke researchers helped pave the way for FDA panel to greenlight Covid-19 vaccine for young kids"

"After receiving the green light from an advisory panel, the FDA is expected to issue an emergency authorization of the Pfizer Covid-19 vaccine for children ages 5 to 11. One set of trials leading up to that approval was held at Duke University."

To read the full article from WHQR, click here.

Related

NPR: "Omicron evades Moderna vaccine too, study suggests, but boosters help"
Duke Health: "Duke Institute Lands Federal Contract to Make Vaccine Candidates"
The Washington Times: "Lab teams race to test vaccines’ strength against omicron variant"
NIH Director's Blog "Accelerating COVID-19 Vaccine Testing with ‘Correlates of Protection’"
WRAL: "Test developed at Duke can quickly tell who's got antibodies to fight which coronavirus variant"
Wired: "The Race Is On to Develop a Vaccine Against Every Coronavirus"
Popular Science: "Why are kids’ immune systems different from adults?"
WHQR: "Duke researchers helped pave the way for FDA panel to greenlight Covid-19 vaccine for young kids"
CBS17: "Mixing vaccines for boosters could produce higher antibody response, new study shows"
DDN: "Designing vaccines with reverse vaccinology"
Duke Human Vaccine Institute


Innovation, Collaboration, Excellence

  • About Us
  • Programs and Centers
  • Diseases & Research
  • Intranet
  • News & Events
  • Careers
  • Give
  • Contact Us
  • Terms & Conditions Policy

Stay Up To Date

Join our mailing list for the latest news, updates and more.

Duke Health School of Medicine Duke University
Copyright © 2004-2022 Duke University Health System